Francesca Llopis-Puigmarti

  • Citations Per Year
Learn More
To the Editor: Early diagnosis is likely to improve the outcome and prognosis of most solid tumors, including biologically aggressive, chemotherapy-refractory gastric carcinomas (GC). Current clinical biomarkers in GC, however, lack the sensitivity and specificity required for screening an asymptomatic population for the purpose of early detection [1].(More)
This study aimed to improve gastric cancer (GC) diagnosis by identifying and validating an INflammatory PROtein-driven GAstric cancer Signature (hereafter INPROGAS) using low-cost affinity proteomics. The detection of 120 cytokines, 43 angiogenic factors, 41 growth factors, 40 inflammatory factors and 10 metalloproteinases was performed using commercially(More)
  • 1